doi: 10.1016/j.biopha.2017.08.009
In that work, BPC-157 was applied shortly after the nerve was cut intraperitoneally, intragastrically, locally at the anastomosis site, or delivered into a tube bridging a resected 7 mm nerve gap and outcomes were tracked over one to two months
Just Opened the Door to Twelve More Disseminated on behalf of The Precision Peptide Company SYMBOL | CSE: BPC | OTCQB: PNGAF Outstanding Shares: 47,231,207 Warrants: 8,396,600 Options: 2,733,333 Fully Diluted: 54,699,540 ThePrecisionPeptideCompany.com The Precision Peptide Company (CSE: BPC) is a Vancouver-based natural supplement company that operates in Surrey, British Columbia
Rodriguez 2025 (EHR, n=125,474): 1-year discontinuation 64.8% in non-diabetics vs 46.5% in type 2 diabetes